A2A PharmaJul 1, 20191 min readA2A Pharmaceuticals Appoints CEOUpdated: Feb 7, 2020 A2A Pharmaceuticals Appoints Dr. Sotirios Stergiopoulos Chief Executive OfficerLEARN MORE
A2A co-founded biomea Fusion raises $56MBiomea Fusion, Inc., a precision oncology company dedicated to developing innovative medicines targeting genomically defined alterations...
A2A / Daewoong Pharmaceutical Oncology Agreement A2A Pharmaceuticals Inc. Today Announced a Multi-target Co-development Agreement With Daewoong Pharmaceutical for AI-enhanced Oncology...
Comments